IL17A and myeloid sarcoma: Dysregulated Th17 cell activity and increased IL-17A levels are involved in the pathogenesis of autoimmune diseases characterized by chronic inflammation, including psoriasis (PsO), psoriatic arthritis (PsA), MS, and rheumatoid arthritis (RA) [134].